Prime Medicine (PRME) Other Non-Current Assets (2021 - 2026)

Prime Medicine (PRME) has 6 years of Other Non-Current Assets data on file, last reported at $1.0 million in Q1 2026.

• Quarterly Other Non-Current Assets fell 92.89% year-over-year to $1.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.0 million (down 92.89% YoY) and the FY2025 annual result came in at $13.7 million, down 2.64% from the prior year.
• Other Non-Current Assets retreated to $1.0 million in Q1 2026, from $13.7 million in the prior quarter.
• In the past five years, Other Non-Current Assets ranged from a high of $14.1 million in Q3 2024 to a low of $1.0 million in Q1 2026.
• A 5-year average of $12.9 million and a median of $13.5 million in 2022 frame the typical range for Other Non-Current Assets.
• Annual changes were most pronounced in 2024 — Other Non-Current Assets grew 4.19% — and 2026, when it sank 92.89%.
• Tracing PRME's Other Non-Current Assets over 5 years: stood at $13.5 million in 2022, then changed by 0.0% to $13.5 million in 2023, then rose by 4.19% to $14.1 million in 2024, then fell by 2.64% to $13.7 million in 2025, then sank by 92.7% to $1.0 million in 2026.
• The last three Other Non-Current Assets figures came in at $1.0 million (Q1 2026), $13.7 million (Q4 2025), and $13.7 million (Q3 2025), per Business Quant data.